Related Experiment Videos
Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles.
Richard M Meade1, David P Fairlie2, Jody M Mason3,4
1Department of Biology & Biochemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK.
Molecular Neurodegeneration
|July 24, 2019
Summary
Alpha-synuclein (αS) aggregates cause synucleinopathies like Parkinson's disease. New structural insights into αS native and pathogenic forms are reshaping our understanding of disease mechanisms and pathology.
Area of Science:
- Neuroscience
- Biochemistry
- Structural Biology
Background:
- Alpha-synuclein (αS) is central to synucleinopathies, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA).
- These neurodegenerative diseases are characterized by the deposition of αS aggregates, leading to distinct pathological phenotypes.
Purpose of the Study:
- To reinterpret existing literature on αS pathology in light of new structural data.
- To explore the relationship between αS protein structure and disease pathogenesis.
Main Methods:
- Review and synthesis of current literature.
- Incorporation of recent structural findings from solid-state NMR and cryo-electron microscopy (cryo-EM) of αS fibrils.
- Analysis of both native and pathogenic forms of αS.
Main Results:
- Newly revealed structural information provides a refined understanding of αS aggregation.
- Recent fibril structures offer insights into the molecular basis of distinct pathological phenotypes.
- The structural data impacts the interpretation of αS's role in PD pathogenesis.
Conclusions:
- Emerging structural data is crucial for understanding the molecular mechanisms of synucleinopathies.
- This evolving structural knowledge will guide future research directions in PD and related disorders.
- A deeper understanding of αS structure-pathology relationships is key to developing targeted therapies.